IPSC-derived neuronal cultures expressing the Alzheimer’s disease associated rare TREM2 R47H variant enables the construction of an Aβ-induced gene regulatory network
Soraia MartinsiD, Andreas Müller‐SchiffmanniD, Lars ErichseniD, Martina Bohndorf, Wasco WruckiD, Kristel SleegersiD, Christine Van BroeckhoveniD, Carsten KorthiD, James AdjayeiD
Abstract
Recently, genes associated with immune response and inflammation have been identified as genetic risk factors for late-onset Alzheimers disease (LOAD). One of them is the rare p.Arg47His (R47H) variant within triggering receptor expressed on myeloid cells 2 (TREM2), which has been shown to increase the risk for developing AD 2-3-fold. Here, we report the generation and characterization of a model of LOAD using lymphoblast-derived iPSCs from patients harbouring the R47H mutation in TREM2 (AD TREM2 iPSCs), as well as from control individuals without dementia (CON iPSCs). iPSCs efficiently differentiate into mature neuronal cultures and comparative global transcriptome analysis identified a distinct gene expression profile in AD TREM2 neuronal cultures. Furthermore, manipulation of the iPSC-derived functional neuronal cultures with an A{beta}-S8C dimer highlighted metabolic pathways, phagosome and immune response as the most perturbed pathways in AD TREM2 neuronal cultures. Through the construction of an A{beta}-induced gene regulatory network, we were able to identify an A{beta} signature linked to protein processing in the endoplasmic reticulum (ER) which emphasised ER-stress, as a potential causal role in LOAD. Overall, this study has shown that our AD-iPSC based model can be used for in-depth studies to better understand the molecular mechanisms underlying the etiology of LOAD and provides new opportunities for screening of potential therapeutic targets.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- FWCI
- 1.05
- Field percentile
- top 25%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TREM2 R47H exacerbates immune response in Alzheimer's disease brain
Olena Korvatska, Kostantin Kiianitsa, … Wendy H. Raskind·bioRxiv·Aug 4, 2020
- Trem2*R47H and reduced TREM2 expression both mimic human Alzheimer's disease signatures in mice
T. Abel, Ravi S. Pandey, … Gregory W. Carter·bioRxiv·Dec 19, 2025
- The TREM2-R47H Variant Drives Alzheimer's-Relevant Alterations in Forebrain Organoids Beyond Microglial Populations
Aigerim S. Kamzina, Kate E Leinenweber, … Matthew J. Huentelman·bioRxiv·May 3, 2026
- Microglial signalling pathway deficits associated with the R47H TREM2 variant linked to AD indicate inability to activate inflammasome
Katharina Cosker, Anna Mallach, … Jennifer M. Pocock·Scientific ReportsPeer-reviewed·Jun 25, 2021
- Trem2 R47H mutation shows mild, but functionally divergent alterations in microglial phenotypes compared to Trem2 deficiency in aged AppNL-F knock-in mice
Keiro Shirotani, Daisuke Hatta, … Nobuhisa Iwata·Experimental NeurologyPeer-reviewed·Jun 24, 2026
- BAC Transgenic Expression of Human TREM2-R47H Remodels Amyloid Plaques but Unable to Reprogram Plaque-associated Microglial Reactivity in 5xFAD Mice
C.Y. Daniel Lee, Amberlene J. De La Rocha, … X. William Yang·bioRxiv·Aug 3, 2023